Lymphocyte phenotyping in infants: Maturation of lymphocyte subpopulations and the effects of HIV infection

Clinical Immunology and Immunopathology

Volumn 85, Issue 3, 1997, Pages 273-281

  Rich, Kenneth C ^a   Brambilla, Donald ^b   Pitt, Jane ^c   Moye, Jack ^d   Cooper, Ellen ^e   Hillyer, George ^f   Mendez, Hermann ^g   Fowler, Mary Glenn ^h   Landay, Alan ⁱ  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e BOSTON MEDICAL CENTER   (United States)

^f UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; DNA; HLA DR ANTIGEN; ZIDOVUDINE;

ARTICLE; CELL MATURATION; CHILD; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFANT; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; NEWBORN; PERINATAL INFECTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031393698     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4439     Document Type: Article

References (37)

1. Lagakos S. W., Hoth D. F. Editorials: Surrogate markers in AIDS - Where are we? Where are we going? Ann. Intern. Med. 116:1992;599-601.
2. Blatt S. P., McCarthy W. F., Bucko-Krasnicka B., Melcher G. P., Boswell R. N., Dolan M. J., Freeman T. M., Rusnak J. M., Hensley R. E., Ward W. W., Barnes D., Hendrix C. W. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J. Infect. Dis. 171:1995;837-844.
3. Landay A., Ohlsson-Wilhelm B., Giorgi J. V. Editorial reviews: Application of flow cytometry to the study of HIV infection. AIDS. 4:1990;479-497.
4. Giorgi J. V., Ho H-N., Hirji K., Chou C-C., Hultin L. E., O'Rourke S., Park L., Margolick J. B., Ferbas J., Phair J. P. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: Development of HLA-DR+CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. J. Infect. Dis. 170:1994;775-781.
5. Chevret S., Roquin H., Ganne P., Lefrere J. J. Prognostic value of an elevated CD8 lymphocyte count in HIV infection: Results of a prospective study of 152 asymptomatic HIV-positive individuals. AIDS. 6:1992;1349-1352.
6. Plaeger-Marshall S., Hultin P., Bertolli J., O'Rourke S., Kaboyashi R., Kobayashi A. L., Giorgi J. V., Bryson Y., Stiehm E. R. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J. Acquired Immune Defic. Syndr. 6:1993;984-993.
7. Ibegbu C., Spira T. J., Nesheim S., Mendez H., Lee F., Polliotti B., Caba J., Nahmias A. Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults. Clin. Immunol. Immunopathol. 71:1994;27-32.
8. Vagano A., Stasi P., Salvaggio A., Marchisio P., Principi N. Patterns of T lymphocyte changes in early diagnosis of vertically acquired HIV infection. Pediatr. AIDS HIV Infect. 4:1993;192-194.
9. Denny T., Yogev R., Gelman R., Skuza C., Oleske J., Chadwick E., Cheng S. C., Conner E. Lymphocyte subsets in healthy children during the first 5 years of life. JAMA. 267:1992;1484-1488.
10. Erkeller-Yuksel F. M., Deneys V., Yuksel B., Hannet I., Hulstaert F., Hamilton C., Mackinnon H., Stokes L. T., Munhyeshuli V., Vanlangendonck F. Age-related changes in human blood lymphocyte subpopulations. J. Pediatr. 120:1992;216-222.
11. Plaeger-Marshall S., Isacescu V., O'Rourke S., Bertolli J., Bryson Y. J., Stiehm E. R. T cell activation in pediatric AIDS pathogenesis: Three-color immunophenotyping. Clin. Immunol. Immunopathol. 71:1994;19-26.
12. McKinney R. E., Wilfert C. M. Lymphocyte subsets in children younger than 2 years old: Normal values in a population at risk for human immunodeficiency virus infection and diagnostic and prognostic application to infected children. Pediatr. Infect. Dis. J. 11:1992;639-644.
13. Pediatr. Infect. Dis. J. 11:1992;1018-1026.
14. Hollinger F. B. ACTG Virology Manual for HIV Laboratories. September 1993;National Institutes of HealthDivision of AIDSNational Institute of Allergy and Infectious Diseases, Bethesda.
15. McIntosh K., Pitt J., Brambilla D., Carroll S., Diaz C., Handelsman E., Moye J., Rich K. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J. Infect. Dis. 170:1994;996-1001.
16. Bremer J. W., Lew J., Cooper E., Hillyer G. V., Pitt J., Handelsman E., Brambilla D., Moye J., Hoff R. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants Transmission Study. J. Pediatr. 129:1996;198-207.
17. Conner E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., Van Dyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:1994;1173-1180.
18. Calvelli T., Denny T. N., Paxton H., Gelman R., Kagan J. Guideline for flow cytometric immunophenotyping: A report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 14:1993;702-715.
19. Landay A. L., Brambilla D., Pitt J., Hillyer G., Golenbock D., Moye J., Kagan J. Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. Clin. Diagn. Lab. Immunol. 2:1995;462-468.
20. Morrison D. F. Multivariate Statistical Methods. 1976;McGraw-Hill, New York.
21. Culver K. W., Ammann A. J., Partridge J. C., Wong D. F., Wara D. W., Cowan M. J. Lymphocyte abnormalities in infants born to drug-abusing mothers. J. Pediatr. 111:1987;230-235.
22. Laurence J. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann. Intern. Med. 119:1993;55-62.
23. Fei D. T., Paxton H., Chen A. B. Difficulties in precise quantitation of CD4+ T lymphocytes for clinical trials: a review. Biologicals. 21:1993;221-231.
24. Rinaldo C., Huang X.-L., Piazza P., Armstrong J., Rappocciolo G., Pazin G., McMahon D., Gupta P., Fan Z., Zhang Z., Ho M. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. J. Infect. Dis. 164:1991;638-645.
25. Sungsub C., Lagakos S. W., Schooley R. T., Volberding P. A. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann. Intern. Med. 118:1993;674-680.
26. Bass H. Z., Hardy W. D., Mitsuyasu R. T., Want Y. X., Cumberland W., Fahey J. L. Eleven lymphoid phenotypic markers in HIV infection: Selective changes induced by zidovudine treatment. J. Acquired Immune Defic. Syndr. 5:1992;890-897.
27. Monforte d'A., Novati R., Galli M., Marchisio P., Massironi E., Tornaghi R., Saracco A., Principi N., Moroni M. T-cell subsets and serum immunoglobulin levels in infants born to HIV-seropositive mothers: A longitudinal evaluation. AIDS. 5:1991;1141-1144.
28. Simonds R. J., Oxtoby M. J., Caldwell M. B., Gwinn M. L., Rogers M. F. Pneumocystis carinii. JAMA. 270:1993;470-473.
29. Gaines H., von Sydow M. A. E., von Stedingk L. V., Biberfeld G., Bottiger B., Hansson L. O., Lundbergh P., Sonnerborg A. B., Wasserman J., Strannegaa O. O. Immunological changes in primary HIV-1 infection. AIDS. 4:1990;995-999.
30. Funaro A., Spagnoli G. C., Ausiello C. M., Alessio M., Roggero S., Delia D., Zaccolo M., Malavasi F. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J. Immunol. 145:1990;2390-2396.
31. Giorgi J. V., Liu Z., Hultin L. E., Cumberland W. G., Hennessey K., Detels R. Elevated levels of CD38+CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up. J. Acquired Immune Defic. Syndr. 6:1993;904-912.
32. Luzuriaga K., McQuilken P., Alimenti A., Somasundaran M. Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J. Infect. Dis. 167:1993;1008-1013.
33. Sadat-Sowti B., Debre P., Idziorek T., Guillon J. M., Hadida F., Okzenhendler E., Katlama C., Mayaud C., Autran B. A lectin-binding soluble factor released by CD8+CD57+ lymphocytes. Eur. J. Immunol. 21:1991;737-741.
34. Khayat D., Soubrane C., Andrieu J. M., Visonneau S., Eme D., Tourani J. M., Beldjord K., Weil M., Fernandez E., Jacquillat C. Changes of soluble CD16 levels in Serum of HIV-infected patients: Correlation with clinical and biologic prognostic factors. J. Infect. Dis. 161:1990;430-435.
35. Amadori A., Zamarchi R., Veronese M. L., Panozzo M., Mazza M. R., Barelli A., Borri A., Chieco-Bianchi L. B-cell activation during HIV-1 infection. III. Down-regulating effect of mitogens. AIDS. 5:1991;821-828.
36. Rich K., Chang B.-H., Mofenson L., Fowler M. G., Cooper E., Pitt J., Hillyer G. V., Mendez H. Elevated CD8+DR+ in HIV exposed infants with early positive HIV cultures: A possible early marker of intrauterine transmission. J. AIDS Hum. Retrovirol. 15:1997;204-210.
37. J. Ferbas, et al. 1992, Increased number of CD57+/CD8+ lymphocytes in HIV infected men, International Conference on AIDS, July 19-24, 1992, 8 (3), 43.